Insider Trading July 1, 2026 05:24 PM

VeriSign Executive Chairman D. James Bidzos Offloads $828K in Shares Amid Recent Earnings Beat

Insider transaction follows first-quarter results that surpassed analyst estimates for earnings per share and revenue, with the stock currently trading near $256.

By Maya Rios
Share
Twitter Reddit Facebook LinkedIn
VRSN

D. James Bidzos, serving as Executive Chairman, President, and CEO of VeriSign Inc., executed a series of sales totaling $828,110 in company common stock on June 30, 2026. The transaction involved the disposition of 3,300 shares, sold at weighted average prices between $248.98 and $252.50. Following these sales, Bidzos retains a direct stake of 426,139.0301 shares. The insider activity occurs against a backdrop of strong first-quarter financial results that exceeded market expectations, with the stock currently trading at $255.90, representing a decline of nearly 12% over the past year despite valuation models suggesting the company may be slightly undervalued at current levels.

VeriSign Executive Chairman D. James Bidzos Offloads $828K in Shares Amid Recent Earnings Beat
VRSN
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Executive Chairman and CEO D. James Bidzos sold 3,300 shares of VeriSign common stock on June 30, 2026, totaling $828,110 at prices between $248.98 and $252.50 per share.
  • VeriSign reported first-quarter 2026 earnings that exceeded expectations, with EPS of $2.34 against a $2.31 forecast and revenue of $429 million versus a $425.16 million projection.
  • The stock currently trades at $255.90, down nearly 12% over the past year, though valuation models suggest the company may be slightly undervalued at current levels.

D. James Bidzos, who holds the titles of Executive Chairman, President, and CEO at VERISIGN INC/CA (NASDAQ:VRSN), completed a divestiture of company equity on June 30, 2026. The total value of the transaction reached $828,110. This financial movement involved the sale of 3,300 shares of VeriSign common stock. The execution of these sales occurred across multiple transactions, with prices ranging from $248.98 to $252.50 per share. The reported figures for these transactions reflect weighted averages. Post-transaction, Mr. Bidzos maintains a direct holding of 426,139.0301 shares of VeriSign common stock.

The insider transaction takes place within a specific market context. VeriSign stock currently trades at $255.90. Over the past year, the share price has declined by nearly 12%. Despite this recent price action, analysis from InvestingPro indicates that the company remains slightly undervalued at its current trading level. This valuation perspective is derived from proprietary models that assess fair value based on industry standards.

Financial performance data provides additional context to the timing of the sale. VeriSign Inc. reported first-quarter earnings for 2026 that surpassed analyst consensus. The company recorded an earnings per share (EPS) of $2.34, exceeding the forecasted $2.31. Revenue for the quarter totaled $429 million, which also beat the projected $425.16 million. These results demonstrate robust operational execution and strong financial performance for the period. Following the earnings announcement, the market reacted positively to the company's ability to surpass both revenue and EPS projections.

The intersection of insider selling and strong earnings highlights the complex dynamics of executive compensation and market valuation. While the sale represents a reduction in direct holdings, the remaining position of over 426,000 shares indicates continued significant ownership. The market's positive reaction to the earnings beat suggests confidence in the company's ability to deliver consistent financial results, even as individual executives manage their personal portfolio allocations.

Risks

  • The stock price has declined nearly 12% over the past year, indicating potential volatility or market sentiment shifts that could impact valuation.
  • Insider selling of significant equity by top executives may signal portfolio rebalancing or liquidity needs, which investors often monitor for changes in confidence.
  • Despite recent earnings beats, the company's valuation remains sensitive to broader market conditions and investor perception of its fair value.

More from Insider Trading

Precigen CFO Thomasian Executes $1.1M Stock Sale Under Pre-Arranged Plan Jul 1, 2026 Revolution Medicines Director Sushil Patel Executes Pre-Arranged Stock Sales Worth $1.05 Million Jul 1, 2026 Alphabet Executive Walker Offloads $3.14M in Class C Shares Under Pre-Arranged Plan Jul 1, 2026 Precigen COO Rutul Shah Executes $251K Stock Sale Under Pre-Arranged Plan Jul 1, 2026 Precigen CEO Helen Sabzevari Executes $2.04 Million Stock Sale Following 262% Surge Jul 1, 2026